T1	Participants 21 63	cryotherapy for retinopathy of prematurity
T2	Participants 163 289	preliminary 3-month outcome of a multicenter randomized trial of cryotherapy for treatment of retinopathy of prematurity (ROP)
T3	Participants 304 339	cryotherapy to the avascular retina
T4	Participants 396 565	threshold disease (defined as five or more contiguous or eight cumulative 30 degree sectors [clock hours] of stage 3 ROP in zone 1 or 2 in the presence of "plus" disease
T5	Participants 711 769	172 infants had been examined 3 months after randomization
